BMJ Editorial, BMA House, London, UK.
BMC Med. 2010 Oct 20;8:62. doi: 10.1186/1741-7015-8-62.
The objectives of this research were (a) to describe the current status of grant review for biomedical projects and programmes from the perspectives of international funding organisations and grant reviewers, and (b) to explore funders' interest in developing uniform requirements for grant review aimed at making the processes and practices of grant review more consistent, transparent, and user friendly.
A survey to a convenience sample of 57 international public and private organisations that give grants for biomedical research was conducted. Nine participating organisations then emailed a random sample of their external reviewers an invitation to participate in a second electronic survey.
A total of 28 of 57 (49%) organisations in 19 countries responded. Organisations reported these problems as frequent or very frequent: declined review requests (16), late reports (10), administrative burden (7), difficulty finding new reviewers (4), and reviewers not following guidelines (4). The administrative burden of the process was reported to have increased over the past 5 years. In all, 17 organisations supported the idea of uniform requirements for conducting grant review and for formatting grant proposals. A total of 258/418 (62%) reviewers responded from 22 countries. Of those, 48% (123/258) said their institutions encouraged grant review, yet only 7% (17/258) were given protected time and 74% (192/258) received no academic recognition for this. Reviewers rated these factors as extremely or very important in deciding to review proposals: 51% (131/258) desire to support external fairness, 47% (120/258) professional duty, 46% (118/258) relevance of the proposal's topic, 43% (110/258) wanting to keep up to date, 40% (104/258) desire to avoid suppression of innovation. Only 16% (42/258) reported that guidance from funders was very clear. In all, 85% (220/258) had not been trained in grant review and 64% (166/258) wanted this.
Funders reported a growing workload of biomedical proposals that is getting harder to peer review. Just under half of grant reviewers take part for the good of science and professional development, but many report lack of academic and practical support and clear guidance. Around two-thirds of funders supported the development of uniform requirements for the format and peer review of proposals to help ease the current situation.
本研究的目的是(a)从国际资助机构和资助评审员的角度描述生物医学项目和计划的资助评审现状,以及(b)探讨资助者对制定统一的资助评审要求的兴趣,旨在使资助评审过程和实践更加一致、透明和用户友好。
对 57 个提供生物医学研究资助的国际公共和私人组织进行了一项便利样本调查。随后,9 个参与组织向其外部评审员的随机样本发送电子邮件邀请他们参加第二次电子调查。
来自 19 个国家的 28 个组织(共 57 个组织中的 49%)做出了回应。组织报告的问题为频繁或非常频繁:拒绝评审请求(16%)、延迟报告(10%)、行政负担(7%)、难以找到新的评审员(4%)和评审员不遵守指南(4%)。过去 5 年来,评审过程的行政负担据报告有所增加。共有 17 个组织支持统一的资助评审要求和资助提案格式的想法。来自 22 个国家的 418 名评审员中的 258 名(62%)做出了回应。其中,48%(123/258)表示他们所在机构鼓励进行资助评审,但只有 7%(17/258)获得了受保护的时间,74%(192/258)没有因此获得学术认可。评审员在决定评审提案时将这些因素评为极其重要或非常重要:51%(131/258)渴望支持外部公平,47%(120/258)为专业职责,46%(118/258)为提案主题的相关性,43%(110/258)为保持最新,40%(104/258)渴望避免抑制创新。只有 16%(42/258)报告说,资助者的指导非常清楚。总的来说,85%(220/258)的人没有接受过资助评审培训,64%(166/258)希望接受培训。
资助者报告称,生物医学提案的工作量不断增加,同行评审越来越困难。近一半的资助评审员是为了科学和专业发展而参与的,但许多人报告缺乏学术和实践支持以及明确的指导。大约三分之二的资助者支持制定统一的提案格式和同行评审要求,以帮助缓解当前的局面。